New gene therapy endorsed

Country

Netherlands

The European Medicines Agency has given a positive opinion to a new gene therapy for cerebral adrenoleukodystrophy (CALD), a rare inherited neurological disease that affects approximately one in 21,000 newborn males. The scientific endorsement, which is the first step towards a formal marketing authorisation, is based on data from a single-arm trial.